medthority

Thrombosis in conversation

Education EN ↓ 33 episodi

Join expert contributors for this podcast series looking at treatment approaches and clinical challenges in venous thromboembolism (VTE), cancer-associated VTE (CAT) and atrial fibrillation (AF).Dr Geoffrey Barnes and guests take on gauging the risk of CAT, and guideline recommendations for VTE and CAT; Professor Gregory Lip and Dr Marco Proietti examine real-world evidence for preventing stroke in people with AF.This podcast is intended for Healthcare Professionals only.

Visita il sito del podcast e sostieni chi lo crea: think-thrombosis.podbean.com

Autore

medthority

Categoria

Education

Sito del podcast

think-thrombosis.podbean.com

Ultimo episodio

4 dic 2025

Dove ascoltare?

I podcast nell'app Replaio Radio In arrivo

I podcast stanno per arrivare nell'app. Installala ora e scopri per primo un modo tutto nuovo di vivere i podcast

Scaricala su Google Play Installala gratis Android 10 mln+ di download · valutazione 4,7+ iOS in arrivo

Episodi

Episode 8: Real-world evidence for managing AF in stroke prevention 19.03.2024

Can real-world evidence improve treatment selection and individualised care for AF in stroke prevention? Dr Proietti and Professor Lip discuss.

Episode 7: AF screening and detection technologies in stroke prevention 19.03.2024

“Wearable technologies for stroke prevention are an exciting trend in the field” Dr Proietti and Professor Lip examine the benefits and disadvantages of wearable technologies for AF screening and detection in stroke prevention.

Episode 6: Treatments and guideline recommendations for managing CAT 04.05.2023

Dr Rajasekhar and Dr Barnes consider treatment selection for CAT, highlighting the role of warfarin, and discuss optimal treatment length and the use of IVC filters according to current guidelines.

Episode 5: Assessment and guideline recommendations for recurrent VTE in patients without cancer 04.05.2023

“Why did a patient get their blood clot in the first place, and how does that influence our decisions?” Dr Barnes is joined by Dr Anita Rajasekhar for a discussion of the causes and risk factors of VTE in people without cancer, and the relationship of risk and cause with treatment selection. With reference to clinical guidance, Dr Rajasekhar talks about diagnosis of recurrent VTE in the clinical s...

Episode 4: Management of challenging CAT and anticoagulation 13.04.2023

Dr Deborah Siegal and Dr Barnes discuss thrombocytopenia and its treatment, including anticoagulation therapy and the inferior vena cava (IVC) filter, and touch on the challenge of balancing bleeding risk with VTE recurrence in people with brain tumours.

Episode 3: Real-world evidence for VTE 13.04.2023

“How do we apply [clinical trial data] to patients we see every day in clinic?” Dr Gregory Piazza and Dr Barnes analyse real-world VTE data, highlighting shared decision-making for determining the most suitable anticoagulation therapy for a person with VTE.

Episode 2: The treatment landscape for CAT 13.04.2023

“If there is a compliance and an adherence issue, it’s with the injectables” Dr Alok Khorana joins Dr Barnes to discuss the real-world versus clinical trial evidence of adherence to injectables, including the importance of taking a patient’s values and preferences into account when making treatment decisions.

Episode 1: Identifying and stratifying risk of CAT 13.04.2023

Dr Alok Khorana and Dr Barnes examine why cancer can drive higher risk of VTE and the importance of warning patients about the symptoms of a blood clot.

Ascolta il podcast Thrombosis in conversation su Replaio

Radio e podcast in un'unica app - gratis e senza registrazione. Installala oggi e non perderti il lancio

Scaricala su Google Play

Replaio non è un editore di podcast; i nomi dei programmi, le copertine e l'audio appartengono ai rispettivi autori e vengono distribuiti tramite feed RSS pubblici